Evidence map›Paper›PMID 33325373›Full record

ArticleJMIR research protocols2020

Remote Assessment of Disease and Relapse in Epilepsy: Protocol for a Multicenter Prospective Cohort Study.

Elisa Bruno, Andrea Biondi, Sebastian Böttcher, Gergely Vértes, Richard Dobson, Amos Folarin, Yatharth Ranjan, Zulqarnain Rashid, Nikolay Manyakov, Aki Rintala and 9 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Epilepsy and COVID 2021.Epilepsy currents
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Elisa BrunoInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-8166-1190
Andrea BiondiInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-1072-665X
Sebastian BöttcherEpilepsy Center, Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0002-3407-8290
Gergely VértesEpilepsy Seizure Detection - Neurology UCB Pharma, Brussels, Belgium.ORCID https://orcid.org/0000-0002-8602-9626
Richard DobsonInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-4224-9245
Amos FolarinInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-0333-1927
Yatharth RanjanInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-3079-3120
Zulqarnain RashidInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-6843-9920
Nikolay ManyakovFeasibility Advanced Analytics, Clinical Insights and Experience, Janssen Research and Development, Beerse, Belgium.ORCID https://orcid.org/0000-0001-9037-1400
Aki RintalaDepartment of Neurosciences, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-0066-4697
Inez Myin-GermeysDepartment of Neurosciences, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-3731-4930
Sara SimblettInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-8075-8238
Til WykesInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-5881-8003
Amanda StonemanThe RADAR-CNS patient advisory board, King's College London, UK, London, United Kingdom.ORCID https://orcid.org/0000-0002-8003-6067
Ann LittleThe RADAR-CNS patient advisory board, King's College London, UK, London, United Kingdom.ORCID https://orcid.org/0000-0002-9587-8507
Sarah ThorpeThe RADAR-CNS patient advisory board, King's College London, UK, London, United Kingdom.ORCID https://orcid.org/0000-0001-8973-3777
Simon LeesThe RADAR-CNS patient advisory board, King's College London, UK, London, United Kingdom.ORCID https://orcid.org/0000-0001-5140-7394
Andreas Schulze-BonhageEpilepsy Center, Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0003-2382-0506
Mark RichardsonInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-8925-3140

Funding

Medical Research Council MC_PC_17214
6 · The paper itself

Abstract

backgroundIn recent years, a growing body of literature has highlighted the role of wearable and mobile remote measurement technology (RMT) applied to seizure detection in hospital settings, whereas more limited evidence has been produced in the community setting. In clinical practice, seizure assessment typically relies on self-report, which is known to be highly unreliable. Moreover, most people with epilepsy self-identify factors that lead to increased seizure likelihood, including mood, behavior, sleep pattern, and cognitive alterations, all of which are amenable to measurement via multiparametric RMT.

objectiveThe primary aim of this multicenter prospective cohort study is to assess the usability, feasibility, and acceptability of RMT in the community setting. In addition, this study aims to determine whether multiparametric RMT collected in populations with epilepsy can prospectively estimate variations in seizure occurrence and other outcomes, including seizure frequency, quality of life, and comorbidities.

methodsPeople with a diagnosis of pharmacoresistant epilepsy will be recruited in London, United Kingdom, and Freiburg, Germany. Participants will be asked to wear a wrist-worn device and download ad hoc apps developed on their smartphones. The apps will be used to collect data related to sleep, physical activity, stress, mood, social interaction, speech patterns, and cognitive function, both passively from existing smartphone sensors (passive remote measurement technology [pRMT]) and actively via questionnaires, tasks, and assessments (active remote measurement technology [aRMT]). Data will be collected continuously for 6 months and streamed to the Remote Assessment of Disease and Relapse-base (RADAR-base) server.

resultsThe RADAR Central Nervous System project received funding in 2015 from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No. 115902. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations. Ethical approval was obtained in London from the Bromley Research Ethics Committee (research ethics committee reference: 19/LO/1884) in January 2020. The first participant was enrolled on September 30, 2020. Data will be collected until September 30, 2021. The results are expected to be published at the beginning of 2022.

conclusionsRADAR Epilepsy aims at developing a framework of continuous data collection intended to identify ictal and preictal states through the use of aRMT and pRMT in the real-life environment. The study was specifically designed to evaluate the clinical usefulness of the data collected via new technologies and compliance, technology acceptability, and usability for patients. These are key aspects to successful adoption and implementation of RMT as a new way to measure and manage long-term disorders. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/21840.

Indexed as

epilepsymedical devicemobile phoneseizurestelemedicine

Identifiers

PMID33325373
PMCPMC7773514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.